Patrick J. Pollard

Patrick J. Pollard

Auto-generated profile, based on publicly available information

Patrick J. Pollard

Henry Wellcome Building for Molecular Physiology, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2005 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
PPP.J. Pollard
P.J. Pollard
JBJ.J. Brière
J.J. Brière
NAN.A. Alam
N.A. Alam
JBJ. Barwell
J. Barwell
EBE. Barclay
E. Barclay
ITI.P.M. Tomlinson
I.P.M. Tomlinson
The nuclear-encoded Krebs cycle enzymes, fumarate hydratase (FH) and succinate dehydrogenase (SDHB, -C and -D), act as tumour suppressors. Germline mutations in FH predispose individuals to leiomyomas and renal cell cancer (HLRCC), whereas mutations in SDH cause paragangliomas and phaeochromocytomas (HPGL). In this study, we have shown that FH-deficient cells and tumours accumulate fumarate and, to a lesser extent, succinate. SDH-deficient tumours principally accumulate succinate. In situ analyses showed that these tumours also have over-expression of hypoxia-inducible factor 1α (HIF1α), activation of HIF1αtargets (such as vascular endothelial growth factor) and high microvessel density. We found no evidence of increased reactive oxygen species in our cells. Our data provide in vivo evidence to support the hypothesis that increased succinate and/or fumarate causes stabilization of HIF1α a plausible mechanism, inhibition of HIF prolyl hydroxylases, has previously been suggested by in vitro studies. The basic mechanism of tumorigenesis in HPGL and HLRCC is likely to be pseudo-hypoxic drive, just as it is in von Hippel–Lindau syndrome.

1 March 2009 in Cell
Verified
Journal Article
Closed access
Massimiliano MazzoneMassimiliano Mazzone
Massimiliano Mazzone
DDDaniela Dettori
Daniela Dettori
RORodrigo Leite de Oliveira
Rodrigo Leite de Oliveira
SLSonja Loges
Sonja Loges
Thomas SchmidtThomas Schmidt
Thomas Schmidt
PCPeter Carmeliet
Peter Carmeliet

1 October 2011 in Cancer Cell
Verified
Journal Article
Open access
JAJulie Adam
Julie Adam
EHEmine Hatipoglu
Emine Hatipoglu
LOLinda O'FLaherty
Linda O'FLaherty
NTNicola Ternette
Nicola Ternette
NSNatasha Sahgal
Natasha Sahgal
PPPatrick J. Pollard
Patrick J. Pollard
The Krebs cycle enzyme fumarate hydratase (FH) is a human tumor suppressor whose inactivation is associated with the development of leiomyomata, renal cysts, and tumors. It has been proposed that activation of hypoxia inducible factor (HIF) by fumarate-mediated inhibition of HIF prolyl hydroxylases drives oncogenesis. Using a mouse model, we provide genetic evidence that Fh1-associated cyst formation is Hif independent, as is striking upregulation of antioxidant signaling pathways revealed by gene expression profiling. Mechanistic analysis revealed that fumarate modifies cysteine residues within the Kelch-like ECH-associated protein 1 (KEAP1), abrogating its ability to repress the Nuclear factor (erythroid-derived 2)-like 2 (Nrf2)-mediated antioxidant response pathway, suggesting a role for Nrf2 dysregulation in FH-associated cysts and tumors.

1 June 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
DMDavid R. Mole
David R. Mole
CBChristine Blancher
Christine Blancher
RCRichard R. Copley
Richard R. Copley
PPPatrick J. Pollard
Patrick J. Pollard
JGJonathan Gleadle
Jonathan Gleadle
PRPeter J. Ratcliffe
Peter J. Ratcliffe
Hypoxia-inducible factor (HIF) controls an extensive range of adaptive responses to hypoxia. To better understand this transcriptional cascade we performed genome-wide chromatin immunoprecipitation using antibodies to two major HIF-α subunits, and correlated the results with genome-wide transcript profiling. Within a tiled promoter array we identified 546 and 143 sequences that bound, respectively, to HIF-1α or HIF-2α at high stringency. Analysis of these sequences confirmed an identical core binding motif for HIF-1α and HIF-2α (RCGTG) but demonstrated that binding to this motif was highly selective, with binding enriched at distinct regions both upstream and downstream of the transcriptional start. Comparison of HIF-promoter binding data with bidirectional HIF-dependent changes in transcript expression indicated that whereas a substantial proportion of positive responses (>20% across all significantly regulated genes) are direct, HIF-dependent gene suppression is almost entirely indirect. Comparison of HIF-1α- versus HIF-2α-binding sites revealed that whereas some loci bound HIF-1α in isolation, many bound both isoforms with similar affinity. Despite high-affinity binding to multiple promoters, HIF-2α contributed to few, if any, of the transcriptional responses to acute hypoxia at these loci. Given emerging evidence for biologically distinct functions of HIF-1α versus HIF-2α understanding the mechanisms restricting HIF-2α activity will be of interest.

1 August 2009 in The Lancet Oncology
Verified
Journal Article
Closed access
FNFrancien H van Nederveen
Francien H van Nederveen
JGJosé Gaal
José Gaal
JFJudith Favier
Judith Favier
EKEsther Korpershoek
Esther Korpershoek
RORogier A Oldenburg
Rogier A Oldenburg
WDWinand Nm Dinjens
Winand Nm Dinjens

17 August 2011 in Nature
Verified
Journal Article
Closed access
CFChristian Frezza
Christian Frezza
LZLiang Zheng
Liang Zheng
OFOri Folger
Ori Folger
KRKartik N. Rajagopalan
Kartik N. Rajagopalan
EMElaine D. MacKenzie
Elaine D. MacKenzie
EGEyal Gottlieb
Eyal Gottlieb